Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: 46 - You Need To See This

Date set for Glasgow drug consumption room crunch talks

A KEY meeting to determine how the UK’s first safe drug consumption room could be trialled in Glasgow will go ahead before the end of this month,…

The National (Scotland)

Businessline Millets Conclave: Krishna Ella calls for GST waiver for millets

The Hindu

Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. So, let's analyze whether Johnson & Johnson (JNJ), Calliditas Therapeutics AB (CALT), and Aurora Cannabis (ACB) are a Buy, Hold, or Sell.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices

U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug

The Independent UK

Free prescription discount cards from GoodRx — What’s the catch?

GoodRx’s prescription savings program offers significant discounts on prescription drugs, but not without some catches

The Independent UK

Communities across Appalachia band together for first-ever 13-state Narcan distribution event

An effort to destigmatize the use of overdose reversal drugs that started as a pilot in two West Virginia counties has expanded to all thirteen states in Appalachia this year

The Independent UK

Syngene plans to invest ₹788 cr. to expand operations in Hyderabad’s Genome Valley

Syngene to invest up to ₹788 cr in Genome Valley, Hyderabad. Expansion to create 1,000 jobs in science over 5 yrs. Inaugurated PROTAC lab & Central Compound Management facility. Ease of doing business & living in Telangana praised by Syngene's non-executive chairperson Kiran Mazumdar Shaw.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

PM Modi to inaugurate infra projects worth ₹57,050 crore in Madhya Pradesh and Chhattisgarh

PM Modi will also lay the foundation stone for 50-bed critical care blocks in nine districts of Chhattisgarh. Read more on The Hindu

The Hindu

3 A-Rated Pharma Stocks to Buy Today

The pharmaceutical industry is expected to grow in the upcoming years, propelled by continual advancements in medicine, aiming to meet the escalating demands for chronic disease treatment and address the needs of an aging population. Therefore, quality pharma stocks Neurocrine Biosciences (NBIX), AbbVie Inc. (ABBV), and Novo Nordisk A/S (NVO),…

StockNews.com

3 Pharma Stocks Surpassing Johnson & Johnson (JNJ)

The pharmaceutical sector is anticipated to thrive as demand grows and technology advances. While Johnson & Johnson (JNJ) receives much attention from investors, I believe Horizon Therapeutics Public Limited (HZNP), Dr. Reddy’s Laboratories (RDY), and Novartis (NVS) are better investments right now. Read on.

StockNews.com

Prescribe to Profits With These 3 Pharma Stocks

The pharma industry looks well-positioned for solid growth in the long term amid the rising incidence of chronic illnesses and technological advancements. So, quality pharma stocks, Eli Lilly and Company (LLY), Merck & Co. (MRK), and Teva Pharmaceutical (TEVA) could be profitable investments. Read on.

StockNews.com

Regulator issues alert over sale of falsified versions of 2 drugs

Drugs regulator Drugs Controller General of India has directed States and Union Territories to keep vigil on sale and distribution of falsified versions of two drugs, liver medication Defitelio and Takeda’s cancer drug Adcetris after alerts from World Health Organization

The Hindu

Wegovy: the slimming drug that keeps Denmark’s economy growing

Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from recession

The Guardian - UK

September Buy, Sell or Hold for This Pharma Sock: Catalyst Pharmaceuticals (CPRX)

Catalyst Pharmaceuticals (CPRX) delivered a robust performance in its last reported quarter. So, is now the right entry point in the stock? Let’s look at its financial metrics to gauge its prospects.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Relay Therapeutics (RLAY) vs. Perrigo Company (PRGO): Which Pharma Stock Holds Better Upside Potential?

The pharmaceutical industry’s prospects look bright, fueled by a rapidly aging population, the rising prevalence of chronic diseases, consistent R&D efforts backed by government funding, and digital transformation. Pharma stocks Relay Therapeutics (RLAY) and Perrigo Company (PRGO) should benefit from the industry tailwinds. But let’s find out which stock holds…

The Hindu

Spurious drugs, worth about ₹1 crore supplied to A.P.

DCA officials in Andhra Pradesh have identified spurious drugs worth over ₹1 crore in Visakhapatnam, Tirupati, Kadapa, Vijayawada and other cities.

The Hindu

Drugs Control Administration unearths spurious medicine racket in Vijayawada

Drugs Control Administration busts spurious drug racket in Vijayawada. Fake drugs falsely labelled as products of reputed pharma companies were found. These drugs can cause severe health damage and even death. FIR registered against two persons under IPC sections. 24 samples sent to Drug Control Lab, 6 declared sub-standard. Original…

StockNews.com

Is Flora Growth (FLGC) a Good Agriculture Stock Buy Right Now?

Flora Growth (FLGC) entered a new partnership recently to grow its presence in Europe. Moreover, as the European Union moves toward de-scheduling narcotics, is this the right time to scoop up FLGC shares? Read on.

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Experts question Ministry on reversal of provisions targeting inappropriate AYUSH advertisements

Previously the Ministry of AYUSH signed an MoU with ASCI for two years to undertake monitoring of AYUSH-related advertisements.

The Hindu

Drugs regulator issues alert after pharma firm Abbott India recalls antacid syrup Digene Gel

The public notice issued by the apex drug controller on its website said: “The impugned product may be unsafe and its use may result in adverse reaction.”

StockNews.com

3 Pharma Stocks Smart Money Is Following in September

With the rising prevalence of chronic diseases, the demand for pharmaceutical products is anticipated to rise. Therefore, investors could consider buying three fundamentally robust pharma stocks, Eli Lilly and Company (LLY), Zoetis (ZTS), and Taro Pharmaceutical Industries (TARO), which are gaining traction among institutional investors this month. Learn more….

Evening Standard

Hundreds of women taking legal action against Bayer over Essure sterilisation device

The Essure device reportedly left many women suffering ‘excrutiating pain’ and other symptoms

The Independent UK

Hundreds of women left in ‘excruciating pain’ from contraceptive coil launch legal action

‘I was in pain pretty much every day. And then I started having periods that lasted 28-30 days at a time,’ woman says

The Guardian - UK

Two hundred UK women can take legal action over Essure contraceptive device

Group claim able to proceed against maker Bayer after women said implant caused pain, BBC reports

The Guardian - UK

Wegovy maker Novo Nordisk becomes Europe’s most valuable firm

Launch of weight-loss drug in UK helps Danish firm to market value of $428bn

1 … 45 46 47 48

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.